About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 536761, 12 pages
http://dx.doi.org/10.1155/2012/536761
Review Article

How Do Cytokines Trigger Genomic Instability?

1Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
22nd Department of Propedeutic Surgery, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
3Department of Anatomy, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece
4Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 11635 Athens, Greece

Received 25 January 2012; Accepted 8 April 2012

Academic Editor: Vassilis Gorgoulis

Copyright © 2012 Ioannis L. Aivaliotis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. I. Grivennikov, F. R. Greten, and M. Karin, “Immunity, inflammation, and cancer,” Cell, vol. 140, no. 6, pp. 883–899, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Ehrilch, “Ueber den jetzigen stand der karzinomforschung,” Nederlands Tijdschrift voor Geneeskunde, vol. 5, part 1, pp. 273–290, 1909.
  3. L. Thomas, “Discussion,” in Cellular and Humoral Aspects of the Hypersensitive States, H. S. Lawrence, Ed., pp. 529–532, Hoeber-Harper, New York, NY, USA, 1959.
  4. F. M. Burnet, “The concept of immunological surveillance,” Progress in Experimental Tumor Research, vol. 13, pp. 1–27, 1970. View at Scopus
  5. G. P. Dunn, L. J. Old, and R. D. Schreiber, “The three Es of cancer immunoediting,” Annual Review of Immunology, vol. 22, pp. 329–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. B. F. Zamarron and W. Chen, “Dual roles of immune cells and their factors in cancer development and progression,” International Journal of Biological Sciences, vol. 7, no. 5, pp. 651–658, 2011. View at Scopus
  8. J. Han and R. J. Ulevitch, “Limiting inflammatory responses during activation of innate immunity,” Nature Immunology, vol. 6, no. 12, pp. 1198–1205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Shacter and S. A. Weitzman, “Chronic inflammation and cancer,” Oncology, vol. 16, no. 2, pp. 217–230, 2002. View at Scopus
  10. W. W. Lin and M. Karin, “A cytokine-mediated link between innate immunity, inflammation, and cancer,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1175–1183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Markiewski and J. D. Lambris, “Is complement good or bad for cancer patients? A new perspective on an old dilemma,” Trends in Immunology, vol. 30, no. 6, pp. 286–292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Bergonzini, C. Salata, A. Calistri, C. Parolin, and G. Palù, “View and review on viral oncology research,” Infectious Agents and Cancer, vol. 5, no. 1, p. 11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Takahashi, H. Ogata, R. Nishigaki, D. H. Broide, and M. Karin, “Tobacco smoke promotes lung tumorigenesis by triggering IKKβ- and JNK1-dependent inflammation,” Cancer Cell, vol. 17, no. 1, pp. 89–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Dostert, V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp, “Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica,” Science, vol. 320, no. 5876, pp. 674–677, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. R. N. Apte and E. Voronov, “Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy?” Immunological Reviews, vol. 222, no. 1, pp. 222–241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Terzić, S. Grivennikov, E. Karin, and M. Karin, “Inflammation and colon cancer,” Gastroenterology, vol. 138, no. 6, pp. 2101–e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. D. I. Gabrilovich and S. Nagaraj, “Myeloid-derived suppressor cells as regulators of the immune system,” Nature Reviews Immunology, vol. 9, no. 3, pp. 162–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. K. Biswas and A. Mantovani, “Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm,” Nature Immunology, vol. 11, no. 10, pp. 889–896, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Condeelis and J. W. Pollard, “Macrophages: obligate partners for tumor cell migration, invasion, and metastasis,” Cell, vol. 124, no. 2, pp. 263–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. J. Schetter, N. H. H. Heegaard, and C. C. Harris, “Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways,” Carcinogenesis, vol. 31, no. 1, Article ID bgp272, pp. 37–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. F. R. Balkwill, “The chemokine system and cancer,” The Journal of Pathology, vol. 226, no. 2, pp. 148–157, 2012. View at Publisher · View at Google Scholar
  24. J. B. Swann and M. J. Smyth, “Immune surveillance of tumors,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1137–1146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Yu, D. Pardoll, and R. Jove, “STATs in cancer inflammation and immunity: a leading role for STAT3,” Nature Reviews Cancer, vol. 9, no. 11, pp. 798–809, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. I. Grivennikov and M. Karin, “Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer,” Cytokine and Growth Factor Reviews, vol. 21, no. 1, pp. 11–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Ferrone and G. Dranoff, “Dual roles for immunity in gastrointestinal cancers,” Journal of Clinical Oncology, vol. 28, no. 26, pp. 4045–4051, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Karin, “Nuclear factor-κB in cancer development and progression,” Nature, vol. 441, no. 7092, pp. 431–436, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. N. D. Perkins, “Integrating cell-signalling pathways with NF-κB and IKK function,” Nature Reviews Molecular Cell Biology, vol. 8, no. 1, pp. 49–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Zenz and E. F. Wagner, “Jun signalling in the epidermis: from developmental defects to psoriasis and skin tumors,” International Journal of Biochemistry and Cell Biology, vol. 38, no. 7, pp. 1043–1049, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Carmi, E. Voronov, S. Dotan et al., “The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis,” Journal of Immunology, vol. 183, no. 7, pp. 4705–4714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Elkabets, V. S. G. Ribeiro, C. A. Dinarello et al., “IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function,” European Journal of Immunology, vol. 40, no. 12, pp. 3347–3357, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, “Oxidative stress, inflammation, and cancer: how are they linked?” Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. J. J. Waugh and C. Wilson, “The interleukin-8 pathway in cancer,” Clinical Cancer Research, vol. 14, no. 21, pp. 6735–6741, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Yang, M. Bocchetta, B. Kroczynska et al., “TNF-α inhibits asbestos-induced cytotoxicity via a NF-κB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10397–10402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. M. L. Cho, J. W. Kang, Y. M. Moon et al., “STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice,” Journal of Immunology, vol. 176, no. 9, pp. 5652–5661, 2006. View at Scopus
  37. J. S. Hao and B. E. Shan, “Immune enhancement and anti-tumour activity of IL-23,” Cancer Immunology, Immunotherapy, vol. 55, no. 11, pp. 1426–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. K. W. Moore, R. W. Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001.
  39. S. Alas, C. Emmanouilides, and B. Bonavida, “Inhibition of interleukin 10 by Rituximab results in down-regulation of Bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis,” Clinical Cancer Research, vol. 7, no. 3, pp. 709–723, 2001. View at Scopus
  40. S. B. Jakowlew, “Transforming growth factor-β in cancer and metastasis,” Cancer and Metastasis Reviews, vol. 25, no. 3, pp. 435–457, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Rodier, J. P. Coppé, C. K. Patil et al., “Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion,” Nature Cell Biology, vol. 11, no. 8, pp. 973–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. G. P. Dimri, “What has senescence got to do with cancer?” Cancer Cell, vol. 7, no. 6, pp. 505–512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Fumagalli and F. d'Adda di Fagagna, “SASPense and DDRama in cancer and ageing,” Nature Cell Biology, vol. 11, no. 8, pp. 921–923, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. V. G. Gorgoulis and T. D. Halazonetis, “Oncogene-induced senescence: the bright and dark side of the response,” Current Opinion in Cell Biology, vol. 22, no. 6, pp. 816–827, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. C. Acosta and J. Gil, “A role for CXCR2 in senescence, but what about in cancer?” Cancer Research, vol. 69, no. 6, pp. 2167–2170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. V. Orjalo, D. Bhaumik, B. K. Gengler, G. K. Scott, and J. Campisi, “Cell surface-bound IL-1α is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 40, pp. 17031–17036, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Negrini, V. G. Gorgoulis, and T. D. Halazonetis, “Genomic instability an evolving hallmark of cancer,” Nature Reviews Molecular Cell Biology, vol. 11, no. 3, pp. 220–228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. V. G. Gorgoulis, L. V. F. Vassiliou, P. Karakaidos et al., “Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions,” Nature, vol. 434, no. 7035, pp. 907–913, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. T. D. Halazonetis, V. G. Gorgoulis, and J. Bartek, “An oncogene-induced DNA damage model for cancer development,” Science, vol. 319, no. 5868, pp. 1352–1355, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. W. C. Burhans and M. Weinberger, “DNA replication stress, genome instability and aging,” Nucleic Acids Research, vol. 35, no. 22, pp. 7545–7556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Aziz, S. Nowsheen, G. Pantelias, G. Iliakis, V. G. Gorgoulis, and A. G. Georgakilas, “Targeting DNA damage and repair: embracing the pharmacological era for successful cancer therapy,” Pharmacology and Therapeutics, vol. 133, no. 3, pp. 334–350, 2012. View at Publisher · View at Google Scholar
  52. J. Bartkova, Z. Horejsi, K. Koed et al., “DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis,” Nature, vol. 434, no. 7035, pp. 864–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. T. A. Waldmann, “The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design,” Nature Reviews Immunology, vol. 6, no. 8, pp. 595–601, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Martinez-Moczygemba and D. P. Huston, “Biology of common β receptor-signaling cytokines: IL-3, IL-5, and GM-CSF,” Journal of Allergy and Clinical Immunology, vol. 112, no. 4, pp. 653–666, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Hosoyama, M. I. Aslam, J. Abraham et al., “IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma,” Clinical Cancer Research, vol. 17, no. 9, pp. 2757–2766, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Geijsen, L. Koenderman, and P. J. Coffer, “Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family,” Cytokine and Growth Factor Reviews, vol. 12, no. 1, pp. 19–25, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Sawa, Y. Arima, H. Ogura et al., “Hepatic interleukin-7 expression regulates T cell responses,” Immunity, vol. 30, no. 3, pp. 447–457, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Knoops and J. C. Renauld, “IL-9 and its receptor: from signal transduction to tumorigenesis,” Growth Factors, vol. 22, no. 4, pp. 207–215, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Blankenstein, “The role of tumor stroma in the interaction between tumor and immune system,” Current Opinion in Immunology, vol. 17, no. 2, pp. 180–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. P. C. Heinrich, I. Behrmann, S. Haan, H. M. Hermanns, G. Müller-Newen, and F. Schaper, “Principles of interleukin (IL)-6-type cytokine signalling and its regulation,” Biochemical Journal, vol. 374, no. 1, pp. 1–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. W. T. Watford, B. D. Hissong, J. H. Bream, Y. Kanno, L. Muul, and J. J. O'Shea, “Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4,” Immunological Reviews, vol. 202, pp. 139–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Wills-Karp, “Interleukin-13 in asthma pathogenesis,” Immunological Reviews, vol. 202, pp. 175–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Nogami, S. Satoh, M. Nakano et al., “Taxilin; a novel syntaxin-binding protein that is involved in Ca2+-dependent exocytosis in neuroendocrine cells,” Genes to Cells, vol. 8, no. 1, pp. 17–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. W. Cruikshank and F. Little, “Interleukin-16: the ins and outs of regulating T-cell activation,” Critical Reviews in Immunology, vol. 28, no. 6, pp. 467–483, 2008. View at Scopus
  65. M. Numasaki, M. Watanabe, T. Suzuki et al., “IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis,” Journal of Immunology, vol. 175, no. 9, pp. 6177–6189, 2005. View at Scopus
  66. F. Benchetrit, A. Ciree, V. Vives et al., “Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism,” Blood, vol. 99, no. 6, pp. 2114–2121, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Lebel-Binay, A. Berger, F. Zinzindohoué et al., “Interleukin-18: biological properties and clinical implications,” European Cytokine Network, vol. 11, no. 1, pp. 15–25, 2000. View at Scopus
  68. J. K. Kundu and Y. J. Surh, “Emerging avenues linking inflammation and cancer,” Free Radical Biology & Medicine, vol. 52, no. 9, pp. 2013–2037, 2012.
  69. J. Zhang, L. Patel, and K. J. Pienta, “Targeting chemokine (C-C motif) Ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic,” Progress in Molecular Biology and Translational Science C, vol. 95, pp. 31–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Homey, A. Müller, and A. Zlotnik, “Chemokines: agents for the immunotherapy of cancer?” Nature Reviews Immunology, vol. 2, no. 3, pp. 175–184, 2002. View at Scopus
  71. A. P. Vicari, S. Ait-Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux, “Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms,” Journal of Immunology, vol. 165, no. 4, pp. 1992–2000, 2000. View at Scopus
  72. A. Müller, B. Homey, H. Soto et al., “Involvement of chemokine receptors in breast cancer metastasis,” Nature, vol. 410, no. 6824, pp. 50–56, 2001. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Karin, “The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease,” Journal of Leukocyte Biology, vol. 88, no. 3, pp. 463–473, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. D. Blanco, S. Vicent, M. F. Fragaz et al., “Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathway,” Neoplasia, vol. 9, no. 10, pp. 840–852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. S. Cianfarani, B. Tedeschi, D. Germani et al., “In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes,” European Journal of Clinical Investigation, vol. 28, no. 1, pp. 41–47, 1998. View at Publisher · View at Google Scholar · View at Scopus
  76. V. J. Thannickal and B. L. Fanburg, “Reactive oxygen species in cell signaling,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 279, no. 6, pp. L1005–L1028, 2000. View at Scopus
  77. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Katsuyama, “NOX/NADPH oxidase, the superoxide-generating enzyme: its transcriptional regulation and physiological roles,” Journal of Pharmacological Sciences, vol. 114, no. 2, pp. 134–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. P. Ghafourifar and E. Cadenas, “Mitochondrial nitric oxide synthase,” Trends in Pharmacological Sciences, vol. 26, no. 4, pp. 190–195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Pautz, J. Art, S. Hahn, S. Nowag, C. Voss, and H. Kleinert, “Regulation of the expression of inducible nitric oxide synthase,” Nitric Oxide, vol. 23, no. 2, pp. 75–93, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. C. J. Lowenstein and E. Padalko, “iNOS (NOS2) at a glance,” Journal of Cell Science, vol. 117, no. 14, pp. 2865–2867, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Poli, G. Leonarduzzi, F. Biasi, and E. Chiarpotto, “Oxidative stress and cell signalling,” Current Medicinal Chemistry, vol. 11, no. 9, pp. 1163–1182, 2004. View at Scopus
  83. M. Liontos, I. S. Pateras, K. Evangelou, and V. G. Gorgoulis, “The tumor suppressor gene ARF as a sensor of oxidative stress,” Current Molecular Medicine. In press.
  84. S. P. Hussain, L. J. Hofseth, and C. C. Harris, “Radical causes of cancer,” Nature Reviews Cancer, vol. 3, no. 4, pp. 276–285, 2003. View at Scopus
  85. I. L. C. Chapple, “Reactive oxygen species and antioxidants in inflammatory diseases,” Journal of Clinical Periodontology, vol. 24, no. 5, pp. 287–296, 1997. View at Scopus
  86. A. Sturrock, B. Cahill, K. Norman et al., “Transforming growth factor-β1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 290, no. 4, pp. L661–L673, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Sturrock, T. P. Huecksteadt, K. Norman et al., “Nox4 mediates TGF-β1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells,” American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 292, no. 6, pp. L1543–L1555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. I. Cucoranu, R. Clempus, A. Dikalova et al., “NAD(P)H oxidase 4 mediates transforming growth factor-β1-induced differentiation of cardiac fibroblasts into myofibroblasts,” Circulation Research, vol. 97, no. 9, pp. 900–907, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. I. Carmona-Cuenca, C. Roncero, P. Sancho et al., “Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity,” Journal of Hepatology, vol. 49, no. 6, pp. 965–976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Y. Kim, J. W. Lee, H. C. Ryu, J. D. Wei, C. M. Seong, and J. H. Kim, “Proinflammatory cytokine IL-1β stimulates IL-8 synthesis in mast cells via a leukotriene B4 receptor 2-linked pathway, contributing to angiogenesis,” Journal of Immunology, vol. 184, no. 7, pp. 3946–3954, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, “Free radicals and antioxidants in normal physiological functions and human disease,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Roessner, D. Kuester, P. Malfertheiner, and R. Schneider-Stock, “Oxidative stress in ulcerative colitis-associated carcinogenesis,” Pathology Research and Practice, vol. 204, no. 7, pp. 511–524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. C. A. Martey, S. J. Pollock, C. K. Turner et al., “Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer,” American Journal of Physiology, vol. 287, no. 5, pp. L981–L991, 2004. View at Publisher · View at Google Scholar · View at Scopus
  94. G. Garcea, A. R. Dennison, W. P. Steward, and D. P. Berry, “Role of inflammation in pancreatic carcinogenesis and the implications for future therapy,” Pancreatology, vol. 5, no. 6, pp. 514–529, 2005. View at Publisher · View at Google Scholar · View at Scopus
  95. S. J. Murphy, L. A. Anderson, B. T. Johnston et al., “Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study,” World Journal of Gastroenterology, vol. 11, no. 46, pp. 7290–7295, 2005. View at Scopus
  96. R. Visconti and D. Grieco, “New insights on oxidative stress in cancer,” Current Opinion in Drug Discovery and Development, vol. 12, no. 2, pp. 240–245, 2009. View at Scopus
  97. M. Dizdaroglu, P. Jaruga, M. Birincioglu, and H. Rodriguez, “Free radical-induced damage to DNA: mechanisms and measurement,” Free Radical Biology and Medicine, vol. 32, no. 11, pp. 1102–1115, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Gloire, S. Legrand-Poels, and J. Piette, “NF-κB activation by reactive oxygen species:fifteen years later,” Biochemical Pharmacology, vol. 72, no. 11, pp. 1493–1505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  99. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Scopus
  100. S. P. Hussain and C. C. Harris, “Inflammation and cancer: an ancient link with novel potentials,” International Journal of Cancer, vol. 121, no. 11, pp. 2373–2380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. G. Mignot, E. Ullrich, M. Bonmort et al., “The critical role of IL-15 in the antitumor effects mediated by the combination therapy imatinib and IL-2,” Journal of Immunology, vol. 180, no. 10, pp. 6477–6483, 2008. View at Scopus
  102. M. G. Lechner, S. M. Russell, R. S. Bass, and A. L. Epstein, “Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors,” Immunotherapy, vol. 3, no. 11, pp. 1317–1340, 2011. View at Publisher · View at Google Scholar